Trial · NCT07902336
Empathy and Communication Training Program for Psychiatric Nurse Specialists in Saudi Arabia (ECTP)
NCT07902336, Not applicable, Completed, Lincoln University College
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Empathy and Communication Training Program for Psychiatric Nurse Specialists in Saudi Arabia (ECTP). Trials, record NCT07902336. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07902336
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Empathy and Communication Training Program for Psychiatric Nurse Specialists in Saudi Arabia (ECTP)
- NCT number
- NCT07902336
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 154 participants, actual
- Lead sponsor
- Lincoln University College
- Conditions
- Therapeutic Engagement, Psychiatric Nursing, Nurse-Patient Relations, Empathy, Communication
- Interventions
- Usual institutional training (Madinah), ECTP (Dammam)
- First posted
- 2026-10-28
- Last updated
- 2026-10-28
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in overall nurse-reported patient therapeutic engagement (PTE) score | Baseline (Day 1) and immediately after Day 5 of the program (August 2026) | Overall score on the 15-item nurse-reported PTE questionnaire, adapted from the Therapeutic Engagement Questionnaire. Each item is rated from 1 (strongly disagree) to 5 (strongly agree). Items 5, 9 and 10 describe barriers and are reverse-scored (6 minus the original value). The overall score is the mean of all 15 items (range 1 to 5). Higher scores mean more favourable therapeutic engagement. The outcome is the change from baseline to post-test, compared between the intervention group (Dammam) and the control group (Madinah). |
| Secondary | Change in Empathy and Communication domain score | Baseline (Day 1) and immediately after Day 5 of the program (August 2026). | Mean of items 1 to 3 of the PTE questionnaire (range 1 to 5). Higher scores mean more favourable engagement. |
| Secondary | Change in Work Environment and Training domain score | Baseline (Day 1) and immediately after Day 5 of the program (August 2026). | Mean of items 4 to 8 of the PTE questionnaire (range 1 to 5), with item 5 reverse-scored. Higher scores mean more favourable engagement. |
| Secondary | Change in Language and Cultural Barriers domain score | Baseline (Day 1) and immediately after Day 5 of the program (August 2026). | Mean of items 9 and 10 of the PTE questionnaire (range 1 to 5), both reverse-scored. Higher scores mean fewer perceived barriers. |
| Secondary | Change in Emotional Preparedness domain score | Baseline (Day 1) and immediately after Day 5 of the program (August 2026). | Mean of items 11 to 15 of the PTE questionnaire (range 1 to 5). Higher scores mean more favourable engagement. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07902336
GET https://conductscience.org/api/trials/v1/NCT07902336/registered